Fosaprepitant Intravenous and Insulin Degludec (U-100) Vials
Determining the interaction of Fosaprepitant Intravenous and Insulin Degludec (U-100) Vials and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: fosaprepitant
Brand name: Emend for Injection
Synonyms: Fosaprepitant
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Fosaprepitant Intravenous-Insulin Degludec (U-200) Prefilled Pens
- Fosaprepitant Intravenous-Insulin degludec and liraglutide
- Fosaprepitant Intravenous-Insulin degludec and liraglutide Subcutaneous
- Fosaprepitant Intravenous-Insulin degludec Subcutaneous
- Fosaprepitant Intravenous-Insulin detemir
- Fosaprepitant Intravenous-Insulin Detemir (Cartridges and Prefilled Syringes)
- Insulin Degludec (U-100) Vials-Foscarnet
- Insulin Degludec (U-100) Vials-Foscarnet Intravenous
- Insulin Degludec (U-100) Vials-Foscarnet Sodium
- Insulin Degludec (U-100) Vials-Foscavir
- Insulin Degludec (U-100) Vials-Fosfomycin
- Insulin Degludec (U-100) Vials-Fosfomycin Tromethamine